Molecular alterations in oral carcinogenesis: significant risk predictors in malignant transformation and tumor progression.

In this study an attempt was made to establish the significance of a battery of molecular alterations and thereby identify risk predictors in oral carcinogenesis. For this purpose, EGFR, Stat3, H-ras, c-myc, p53, cyclin D1, p16, Rb, Ki-67 and Bcl-2 were localized immunohistochemically in normal mucosa (n=12), hyperplasia (n=35), dysplasia (n=25), early stage carcinoma (n=65) and advanced stage carcinoma (n=70). Deregulation occurred at an early stage and the number of alterations increased with disease progression. Using multivariate logistic regression analysis, the significant risk predictor for hyperplasia from normal mucosa was Ki-67 (OR=5.75, p=0.021); the significant risk predictors for dysplasia from hyperplasia were EGFR (OR=12.96, p=0.002), Stat3 (OR=17.16, p=0.0001), p16 (OR=5.50, p=0.039) and c-myc (OR=5.99, p=0.052); the significant risk predictors for early stage carcinoma from dysplasia were p53 (OR=6.63, p=0.0001) and Rb (OR=3.81, p=0.056); and the significant risk predictors for further progression were EGFR (OR=5.50, p=0.0001), Stat3 (OR=4.49, p=0.0001), H-ras (OR=4.05, p=0.001) and c-myc (OR=2.99, p=0.015). Cyclin D1 holds a key position linking upstream signaling pathways to cell cycle regulation. Gene products of the mitogenic signaling pathway play an equally significant role as cell cycle regulatory proteins in the hyperplasia-dysplasia-early-advanced-carcinoma sequence and together may provide a reference panel of markers for use in defining premalignant lesions and predicting the risk of malignant transformation and tumor progression.

[1]  J. Bromberg.  Stat proteins and oncogenesis. , 2002, The Journal of clinical investigation.

[2]  S. Piantadosi,et al.  Advances in Brief Genetic Progression Model for Head and Neck Cancer : Implications for Field Cancerization 1 , 2006 .

[3]  A. Piattelli,et al.  Prevalence of p53, bcl-2, and Ki-67 immunoreactivity and of apoptosis in normal oral epithelium and in premalignant and malignant lesions of the oral cavity. , 2002, Journal of oral and maxillofacial surgery : official journal of the American Association of Oral and Maxillofacial Surgeons.

[4]  B. Têtu,et al.  p53 overexpression in head and neck squamous cell carcinoma: review of the literature. , 1996, European journal of cancer. Part B, Oral oncology.

[5]  M. Ewen,et al.  Ras signalling linked to the cell-cycle machinery by the retinoblastoma protein , 1997, Nature.

[6]  R. Jordan,et al.  Oral cancer in the molecular age. , 2001, Journal of the California Dental Association.

[7]  S. Rybakov,et al.  [Classification of malignant tumors of suprarenal glands]. , 2004, Klinichna khirurhiia.

[8]  Didier Picard,et al.  Chimaeras of Myc oncoprotein and steroid receptors cause hormone-dependent transformation of cells , 1989, Nature.

[9]  J. Turkson,et al.  STAT proteins as novel targets for cancer drug discovery , 2004, Expert opinion on therapeutic targets.

[10]  J. Turkson,et al.  Constitutive activation of Stat3 signaling confers resistance to apoptosis in human U266 myeloma cells. , 1999, Immunity.

[11]  K. Kiguchi,et al.  Disruption of Stat3 reveals a critical role in both the initiation and the promotion stages of epithelial carcinogenesis. , 2004, The Journal of clinical investigation.

[12]  S. Lowe,et al.  Oncogenic ras Provokes Premature Cell Senescence Associated with Accumulation of p53 and p16INK4a , 1997, Cell.

[13]  Richard A. Szucs,et al.  TNM Classification of Malignant Tumors. 5th ed , 1998 .

[14]  K. Fu,et al.  Cell cycle proteins and the development of oral squamous cell carcinoma. , 1999, Oral oncology.

[15]  J. Darnell,et al.  Stat3 as an Oncogene , 1999, Cell.

[16]  J. Moore,et al.  c-myc protein expression in untransformed fibroblasts. , 1991, Oncogene.

[17]  R. Hasina,et al.  Head and neck cancer: the pursuit of molecular diagnostic markers. , 2004, Seminars in oncology.

[18]  J. Sudbø,et al.  Molecular based treatment of oral cancer. , 2003, Oral oncology.

[19]  L. Chyczewskî,et al.  Evaluation of p53 and bcl-2 oncoprotein expression in precancerous lesions of the oral cavity. , 2001, Neoplasma (Bratislava).

[20]  R. Mehrotra,et al.  Expression of p53, cyclin D1 and Ki-67 in pre-malignant and malignant oral lesions: association with clinicopathological parameters. , 2005, Anticancer research.

[21]  J. Megyesi,et al.  Differentiation-dependent expression of signal transducers and activators of transcription (STATs) might modify responses to growth factors in the cancers of the head and neck. , 2003, Cancer letters.

[22]  Y. Geng,et al.  Specific protection against breast cancers by cyclin D1 ablation , 2001, Nature.

[23]  J. Nagpal,et al.  Activation of Stat‐3 as one of the early events in tobacco chewing‐mediated oral carcinogenesis , 2002, Cancer.

[24]  J. Grandis,et al.  Targeting epidermal growth factor receptor in head and neck cancer , 2003 .

[25]  R. Sutherland,et al.  Cyclin D1 and p16INK4A expression predict reduced survival in carcinoma of the anterior tongue. , 1999, Clinical cancer research : an official journal of the American Association for Cancer Research.

[26]  S. Jewell,et al.  Quantitative estimation of PCNA, c-myc, EGFR and TGF-alpha in oral submucous fibrosis--an immunohistochemical study. , 2001, Oral oncology.

[27]  S. Kannan,et al.  Expression of p53 in leukoplakia and squamous cell carcinoma of the oral mucosa: correlation with expression of Ki67 , 1996, Clinical molecular pathology.

[28]  Simon C Watkins,et al.  Constitutive activation of Stat3 signaling abrogates apoptosis in squamous cell carcinogenesis in vivo. , 2000, Proceedings of the National Academy of Sciences of the United States of America.

[29]  B. Lloveras,et al.  Bcl‐2 expression is associated with lymph node metastasis in human ductal breast carcinoma , 1995, International journal of cancer.

[30]  N D Le,et al.  Use of allelic loss to predict malignant risk for low-grade oral epithelial dysplasia. , 2000, Clinical cancer research : an official journal of the American Association for Cancer Research.

[31]  J. Sapp,et al.  c-myc oncoprotein expression in oral precancerous and early cancerous lesions. , 1993, European journal of cancer. Part B, Oral oncology.

[32]  S. Patnaik,et al.  Co-overexpression of p53 and c-myc proteins linked with advanced stages of betel- and tobacco-related oral squamous cell carcinomas from eastern India. , 1998, European journal of oral sciences.

[33]  R. Hruban,et al.  The incidence of p53 mutations increases with progression of head and neck cancer. , 1993, Cancer research.

[34]  M. Fresno,et al.  Expression of cyclin D1 and Ki-67 in squamous cell carcinoma of the oral cavity: clinicopathological and prognostic significance. , 2002, Oral Oncology.

[35]  J. Califano,et al.  Genetic progression and clonal relationship of recurrent premalignant head and neck lesions. , 2000, Clinical cancer research : an official journal of the American Association for Cancer Research.

[36]  D. Saranath,et al.  Expression of bcl-2 and bax in chewing tobacco-induced oral cancers and oral lesions from India , 2009, Pathology Oncology Research.

[37]  R. Ralhan,et al.  Alterations of Rb Pathway Components Are Frequent Events in Patients with Oral Epithelial Dysplasia and Predict Clinical Outcome in Patients with Squamous Cell Carcinoma , 2005, Oncology.

[38]  J. Grandis,et al.  Epidermal growth factor receptor biology in head and neck cancer. , 2006, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[39]  K. Nakashiro,et al.  Constitutive activation of Stat3 correlates with increased expression of the c-Met/HGF receptor in oral squamous cell carcinoma. , 2004, Oncology reports.

[40]  S. Shukla,et al.  Stat3 expression in oral squamous cell carcinoma: association with clinicopathological parameters and survival. , 2006, The International journal of biological markers.

[41]  A. Klein-Szanto,et al.  Markers of proliferation in normal and leukoplakic oral epithelia. , 2000, Oral oncology.

[42]  R. Mesquita,et al.  Cell proliferation markers in the odontogenic keratocyst: effect of inflammation. , 2000, Journal of oral pathology & medicine : official publication of the International Association of Oral Pathologists and the American Academy of Oral Pathology.

[43]  B. Vogelstein,et al.  A genetic model for colorectal tumorigenesis , 1990, Cell.

[44]  Eric Wickstrom,et al.  A c-myc antisense oligodeoxynucleotide inhibits entry into S phase but not progress from G0 to G1 , 1987, Nature.

[45]  J. Grandis,et al.  STAT signaling in head and neck cancer , 2000, Oncogene.

[46]  H. Steller.  Mechanisms and genes of cellular suicide , 1995, Science.

[47]  M. Masuda,et al.  Constitutive activation of signal transducers and activators of transcription 3 correlates with cyclin D1 overexpression and may provide a novel prognostic marker in head and neck squamous cell carcinoma. , 2002, Cancer research.

[48]  Roy Garcia,et al.  STATs in oncogenesis , 2000, Oncogene.

[49]  G. Cooper,et al.  Ras links growth factor signaling to the cell cycle machinery via regulation of cyclin D1 and the Cdk inhibitor p27KIP1 , 1997, Molecular and cellular biology.

[50]  W. Hong,et al.  Activation of p53 gene expression in premalignant lesions during head and neck tumorigenesis. , 1994, Cancer research.

[51]  T. Day,et al.  Oral Cancer and Precancerous Lesions , 2002, CA: a cancer journal for clinicians.

[52]  L. M. Facchini,et al.  The molecular role of Myc in growth and transformation: recent discoveries lead to new insights , 1998, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.

[53]  B. Das,et al.  Oral cancer: reviewing the present understanding of its molecular mechanism and exploring the future directions for its effective management. , 2003, Oral oncology.